Cargando…

Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-Abdominal Abscess Model

Mostrar otras versiones (1)

BACKGROUND: Intra-abdominal candidiasis (IAC) is a prominent invasive fungal infection associated with high mortality. Prompt antifungal therapy and source control are crucial for successful treatment. Echinocandin antifungal drugs are first-line agents. Yet, their clinical effectiveness is highly v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yanan, Prideaux, Brendan, Nagasaki, Yoji, Lee, Min Hee, Chen, Pei-Yu, Blanc, Landry, Ho, Hsinpin, Clancy, Cornelius J, Nguyen, Minh-Hong, Dartois, Veronique, Perlin, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630820/ http://dx.doi.org/10.1093/ofid/ofx163.1229

Ejemplares similares

Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model
por: Zhao, Yanan, et al.
Publicado: (2017)

Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data
por: Zhao, Yanan, et al.
Publicado: (2020)

The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Candida glabrata Colonization Mouse Model
por: Healey, Kelley, et al.
Publicado: (2017)

Visualization of Mycobacterial Biomarkers and Tuberculosis Drugs in Infected Tissue by MALDI-MS Imaging
por: Blanc, Landry, et al.
Publicado: (2018)

1726. Candida albicans Virulence Genes Induced During Intra-abdominal Candidiasis (IAC) in the Absence of Antifungal Exposure Mediate Echinocandin Resistance
por: Clancy, Cornelius J, et al.
Publicado: (2019)

The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination
por: Healey, Kelley R., et al.
Publicado: (2017)

Comparison of echinocandin antifungals
por: Eschenauer, Gregory, et al.
Publicado: (2007)

752. Decreased Echinocandin Resistance among Candida glabrata over an Eleven-Year Period at a University Hospital
por: Raabe, Nathan, et al.
Publicado: (2022)

Tissue Distribution and Penetration of Isavuconazole at the Site of Infection in Experimental Invasive Aspergillosis in Mice with Underlying Chronic Granulomatous Disease
por: Lee, Annie, et al.
Publicado: (2019)

CD101: a novel long‐acting echinocandin
por: Zhao, Yanan, et al.
Publicado: (2016)

Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
por: Healey, Kelley R., et al.
Publicado: (2018)

Echinocandins: A ray of hope in antifungal drug therapy
por: Grover, Neeta D.
Publicado: (2010)

Echinocandins: A ray of hope in antifungal drug therapy
por: Grover, Neeta D.
Publicado: (2010)

Echinocandins – structure, mechanism of action and use in antifungal therapy
por: Szymański, Mateusz, et al.
Publicado: (2022)

Penetration of echinocandins into wound secretion of critically ill patients
por: Gasperetti, Tiziana, et al.
Publicado: (2021)

1727. Candida albicans Phosphatidylinositol-(4,5)-Bisphosphate (PIP2) Directs Aberrant Cytokinesis and Septation in Response to Echinocandins, Which Correlates with Fungicidal Activity and Attenuated Virulence
por: Badrane, Hassan, et al.
Publicado: (2019)

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
por: Ning, Yating, et al.
Publicado: (2022)

High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types
por: Blanc, Landry, et al.
Publicado: (2018)

Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations
por: Sarathy, Jansy, et al.
Publicado: (2019)

Echinocandin-resistant Candida tropicalis Bloodstream Infections
por: Sfeir, Maroun, et al.
Publicado: (2017)

Echinocandin Resistance in Aspergillus fumigatus Has Broad Implications for Membrane Lipid Perturbations That Influence Drug-Target Interactions
por: Satish, Shruthi, et al.
Publicado: (2019)

Differential Regulation of Echinocandin Targets Fks1 and Fks2 in Candida glabrata by the Post-Transcriptional Regulator Ssd1
por: Healey, Kelley R., et al.
Publicado: (2020)

Candida auris Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS
por: Vatanshenassan, Mansoureh, et al.
Publicado: (2019)

In Vitro Characterization of Twenty-One Antifungal Combinations against Echinocandin-Resistant and -Susceptible Candida glabrata
por: Khalifa, Hazim O., et al.
Publicado: (2021)

Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells
por: Garcia-Rubio, Rocio, et al.
Publicado: (2021)

Fungal echinocandin resistance
por: Walker, Louise A., et al.
Publicado: (2010)

Fungal echinocandin resistance
por: Munro, Carol A
Publicado: (2010)

Elevated Vacuolar Uptake of Fluorescently Labeled Antifungal Drug Caspofungin Predicts Echinocandin Resistance in Pathogenic Yeast
por: Jaber, Qais Z., et al.
Publicado: (2020)

Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase
por: Logviniuk, Dana, et al.
Publicado: (2022)

In Vitro Antifungal Susceptibility Profile of Miltefosine against a Collection of Azole and Echinocandins Resistant Fusarium Strains
por: Nosratabadi, Mohsen, et al.
Publicado: (2022)

Impact of immunopathology on the antituberculous activity of pyrazinamide
por: Blanc, Landry, et al.
Publicado: (2018)

Novel Cell Wall Antifungals Reveal a Special Synergistic Activity in pbr1 Mutants Resistant to the Glucan Synthesis Antifungals Papulacandins and Echinocandins
por: Berzaghi, Rodrigo, et al.
Publicado: (2019)

Critical Assessment of Cell Wall Integrity Factors Contributing to in vivo Echinocandin Tolerance and Resistance in Candida glabrata
por: Garcia-Rubio, Rocio, et al.
Publicado: (2021)

Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance
por: Dellière, Sarah, et al.
Publicado: (2016)

Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach
por: Pienaar, Elsje, et al.
Publicado: (2017)

“Illuminating” Echinocandins’ Mechanism of Action
por: Loh, Boon Shing, et al.
Publicado: (2020)

Significantly Improved Pharmacokinetics Enhances In Vivo Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis
por: Zhao, Yanan, et al.
Publicado: (2018)

Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy
por: Zimmerman, Matthew, et al.
Publicado: (2017)

Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance
por: Kordalewska, Milena, et al.
Publicado: (2023)

Emergence of Echinocandin Resistance Due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis
por: Jiménez-Ortigosa, Cristina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2ggaeimujnesl9eoaa95pdf3r9